Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.65
Bid: 8.50
Ask: 8.80
Change: -0.15 (-1.70%)
Spread: 0.30 (3.529%)
Open: 8.58
High: 8.65
Low: 8.58
Prev. Close: 8.80
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agronomics Appoints Comms Consultancy

14 Jun 2023 07:00

RNS Number : 6094C
Agronomics Limited
14 June 2023
 

14 June 2023

Agronomics Limited

("Agronomics" or the "Company")

Agronomics Appoints Comms Consultancy for UK and International Brief

 

Agronomics (ANIC:LSE), the leading listed company focused on the field of cellular agriculture, has appointed SEC Newgate to provide strategic communications support. The brief, which will encompass both UK and international media, will focus on building the profile of the business amongst key investor audiences, as well as increasing awareness of the sector overall.

The strategic comms, advocacy and insight agency won the retained brief after a competitive pitch process. SEC Newgate's team will be led by Director Bob Huxford with support from staff across the agency's Financial Services, Corporate Reputation and Green & Good teams.

Jim Mellon, Co-Founder and Executive Director at Agronomics, commented:

"Agronomics is at an important stage of growth, so we needed the right communications partner who could support our journey and fully integrate with our business strategy. Their team was a standout candidate and clearly understood how best to leverage the expertise of our spokespeople as well as boost visibility for our portfolio companies."

Bob Huxford, Director and Senior Advisor for Investor Relations at SEC Newgate said:

"The sustainable food industry is at an exciting moment in its evolution with advances being made at breakneck speed. We have a strong track record of supporting clients in the environmental space and are delighted to be working with a pioneering business as they transform the global food supply chain."

 

SEC Newgate was recently ranked as a Top 5 ESG Consultancy by PR Week as well as 12th in the PR Week Top 150 Corporate & Financial Consultancies 2023.

 

About Agronomics

Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and be fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

 

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.

 

Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists' claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5℃.

 

AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US $1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital to build out manufacturing facilities. Funding in the field of cellular agriculture is accelerating, however, still, less than US$ 5 billion has been invested worldwide since the industry's inception in 2016.

For further information please contact:

 

Agronomics

Limited

Beaumont

Cornish Limited

Canaccord Genuity Limited

Cenkos

Securities Plc

Peterhouse Capital

Limited

SEC Newgate

The Company

Nomad

Joint Broker

Joint Broker

Joint Broker

Financial Communications

Richard Reed

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Rees

Alex Aylen (Head of Equities)

Giles Balleny

Michael Johnson

Lucy Williams

Charles Goodfellow

Bob Huxford

George Esmond

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 523 8000

+44 (0) 207 397 8900

+44 (0) 207 469 0936

Agronomics@secnewgate.co.uk

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADXLFFXQLBBBV
Date   Source Headline
10th Apr 20137:00 amRNSDirector/PDMR Shareholding
9th Apr 20137:00 amRNSNet Asset Value calculation to 31st March 2013
28th Mar 20137:00 amRNSHalf Yearly Report
8th Feb 20134:50 pmRNSDirector Dealing
8th Feb 20134:45 pmRNSReplacement - Director dealing
30th Jan 20139:55 amRNSDirector Dealing
25th Jan 20133:27 pmRNSNet Asset Value
1st Nov 20127:00 amRNSFinal Results
5th Oct 20122:07 pmRNSNet Asset Value
19th Jul 20123:44 pmRNSDirector/PDMR Shareholding
5th Jul 20121:09 pmRNSNet Asset Value
21st Jun 20127:00 amRNSDirector/PDMR Shareholding
18th Jun 20127:00 amRNSDirector/PDMR Shareholding
13th Jun 20127:00 amRNSDirectorate Change
30th May 201211:40 amRNSDirectorate Change
30th May 201211:14 amRNSHolding(s) in Company
11th Apr 20123:50 pmRNSNet Asset Value
30th Mar 20127:00 amRNSHalf Yearly Report
9th Jan 20123:42 pmRNSNet Asset Value
16th Dec 20114:24 pmRNSChange of Quarterly NAV valuation
20th Oct 20111:46 pmRNSDirector/PDMR Shareholding
14th Oct 20114:43 pmRNSDirector/PDMR Shareholding
14th Oct 201110:53 amRNSInvestment Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.